US Stock MarketDetailed Quotes
BLUE bluebird bio
- 1.130
- +0.090+8.65%
Close Jul 11 16:00 ET
217.80MMarket Cap-1793P/E (TTM)
1.140High1.030Low6.89MVolume1.040Open1.040Pre Close7.48MTurnover3.59%Turnover RatioLossP/E (Static)192.74MShares5.53052wk High0.98P/B216.83MFloat Cap0.84552wk Low--Dividend TTM191.89MShs Float152.883Historical High--Div YieldTTM10.58%Amplitude0.845Historical Low1.084Avg Price1Lot Size
bluebird bio Stock Forum
Sign in to post a comment
$bluebird bio(BLUE.US$ Seems i have majority of posts in this thread since beginning of year! Hehehe! But im going to give one more! IMO from the latest update and from the earnings call! ( Which I recommend you read the earnings call transcript ) I see earnings from this company just getting better and better! IMO im looking for it to just keep growing going forward! And if you read the transcript? Im sure you to will see why i say this. Happy reading![]()
4
2
$bluebird bio(BLUE.US$ Reuters· 1 min ago
Bluebird bio Inc - Anticipates Recognizing Revenue From Its First Infusion of Lyfgenia in Q3 of 2024
Bluebird bio Inc - Anticipates Recognizing Revenue From Its First Infusion of Lyfgenia in Q3 of 2024
1
$bluebird bio(BLUE.US$ Bluebird bio Announces Completion of First Cell Collection for Lyfgenia™ Gene Therapy
$bluebird bio(BLUE.US$ Watching Bluebird Bio; Shares Spike Higher As Traders Circulating Unconfirmed Rumor Suggesting "Lyfgenia Is Among 8 New Therapies In The Running To Receive NTAP Designations At The Start Of FY25. The Emphasis On Supporting Access For SCD Therapies Across HHS Leaves Little Doubt That The New Therapy Will Qualify"
4
2
$bluebird bio(BLUE.US$
NEWS
bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
bluebird bio, Inc. (BLUE) approved inducement grants of 102,700 RSUs to twelve new employees. The RSUs vest equally over four years, in line with NASDAQ rules.
NEWS
bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
bluebird bio, Inc. (BLUE) approved inducement grants of 102,700 RSUs to twelve new employees. The RSUs vest equally over four years, in line with NASDAQ rules.
$bluebird bio(BLUE.US$ Accounting errors they say caused the restatement! So who pays for people’s losses because they went with the original numbers? Hehehe
1
4
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
MARKET-TEST-DUMMY : Seems like more time is needed but heading on the right path to getting patients in line. They seem optimistic as far as the company goes. I'm sure there's a lot of bureaucracy and red tape to getting payments. Like anything else, it should get easier as they go or as they set precedent, so it seems. Not all QTC's are equal and interesting some don't want to be listed on their website though. Wonder if that's a product thing or just not in need of an another patient. Either way, appreciate ya pointing this out. Will be keeping eye on this one too.
TrytosaveabitOP MARKET-TEST-DUMMY: You’re very welcome! Where ya been. I was thinking wow his work musta really picked up. Well at least I’m hoping it was that and nothings gone bad! Anyways good to see ya